Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093357
Filing Date
2024-08-08
Accepted
2024-08-08 08:15:26
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iron-20240630.htm   iXBRL 10-Q 2172352
2 EX-31.1 iron-ex31_1.htm EX-31.1 15229
3 EX-31.2 iron-ex31_2.htm EX-31.2 14937
4 EX-32.1 iron-ex32_1.htm EX-32.1 8638
  Complete submission text file 0000950170-24-093357.txt   8385242

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20240630.xsd EX-101.SCH 1681275
74 EXTRACTED XBRL INSTANCE DOCUMENT iron-20240630_htm.xml XML 1014416
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 241186201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)